| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/29/2010 | WO2010085673A2 Lighting design of high quality biomedical devices |
| 07/29/2010 | WO2010085655A2 Cytometer with automatic continuous alignment correction |
| 07/29/2010 | WO2010085632A2 Virtual core flow cytometry |
| 07/29/2010 | WO2010085606A1 Protein biomarkers and therapeutic targets for osteoarthritis |
| 07/29/2010 | WO2010085586A1 Secreted phospholipase a2 biomarkers for arthritis |
| 07/29/2010 | WO2010085548A2 Single molecule proteomics with dynamic probes |
| 07/29/2010 | WO2010085514A1 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban |
| 07/29/2010 | WO2010085498A1 Single cell gene expression for diagnosis, prognosis and identification of drug targets |
| 07/29/2010 | WO2010085473A1 Methods for the delivery of toxins or enzymatically active portions thereof |
| 07/29/2010 | WO2010085387A2 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
| 07/29/2010 | WO2010085345A1 Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies |
| 07/29/2010 | WO2010085275A1 Compositions and methods for assessing cytotoxicity of single cells |
| 07/29/2010 | WO2010085271A1 Diagnostic multi-layer dry phase test strip with integrated biosensors |
| 07/29/2010 | WO2010085259A1 Viral detection liposomes and method |
| 07/29/2010 | WO2010085251A1 Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from cho cells |
| 07/29/2010 | WO2010085235A1 Selection of head and neck cancer patients for treatment with drugs targeting egfr pathway |
| 07/29/2010 | WO2010085234A1 Selection of colorectal cancer patients for treatment with drugs targeting egfr pathway |
| 07/29/2010 | WO2010085124A2 Marker for liver-cancer diagnosis and recurrence and survival prediction, a kit comprising the same, and prognosis prediction in liver-cancer patients using the marker |
| 07/29/2010 | WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
| 07/29/2010 | WO2010084998A1 A method of predicting the efficacy of a drug |
| 07/29/2010 | WO2010084943A1 Method for evaluating cultured cells |
| 07/29/2010 | WO2010084917A1 Bodily fluid collection device enabling efficient bodily fluid collection and bodily fluid analysis device enabling accurate analysis |
| 07/29/2010 | WO2010084851A1 Peptide capable of binding to immunoglobulin |
| 07/29/2010 | WO2010084680A1 Base for probe array, method for producing same, and method for producing probe array |
| 07/29/2010 | WO2010084626A1 Method for detection of presence of anti-platelet antibody |
| 07/29/2010 | WO2010084383A1 Mixed actuation protocol for a magnetic biosensor device |
| 07/29/2010 | WO2010084327A2 Methods |
| 07/29/2010 | WO2010084312A1 Methods for predicting autoimmune disease risk |
| 07/29/2010 | WO2010084231A1 Genetic construction comprising the gene encoding the kap protein and non-human animal genetically modified therewith |
| 07/29/2010 | WO2010084201A1 Novel derivative of erythromycin for the treatment and diagnosis of prion disease |
| 07/29/2010 | WO2010084196A1 Functionalized microfluidic device for immunofluorescence |
| 07/29/2010 | WO2010084150A1 Diagnostic method for detecting neurodegenerative diseases |
| 07/29/2010 | WO2010084100A1 Soluble icam-1 as biomarker for prediction of therapeutic response |
| 07/29/2010 | WO2010084090A1 Pyridyl-aza(thio)xanthone sensitizer comprising lanthanide(iii) ion complexing compounds, their luminescent lanthanide (iii) ion complexes and use thereof as fluorescent labels. |
| 07/29/2010 | WO2010084015A1 Method for detecting an analyte in a sample by multiplexing fret analysis and kit |
| 07/29/2010 | WO2010083859A1 Device and method for material separation |
| 07/29/2010 | WO2010083852A1 Functionalized microfluidic device for immunofluorescence |
| 07/29/2010 | WO2010083811A1 Method for identifying in particular unknown substances by mass spectrometry |
| 07/29/2010 | WO2010065923A3 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders |
| 07/29/2010 | WO2010064208A3 Msp2 antigenic peptides and their use |
| 07/29/2010 | WO2010063839A3 Targets for treatment of chlamydial infections |
| 07/29/2010 | WO2010057647A3 Methods and compositions for the diagnosis and treatment of diabetes |
| 07/29/2010 | WO2010053976A3 Drug-enhanced neurofeedback |
| 07/29/2010 | WO2010053573A3 Screen for inhibitors of filovirus and uses therefor |
| 07/29/2010 | WO2010048212A3 Methods and compositions for preventing artifacts in tissue samples |
| 07/29/2010 | WO2010046692A3 Non- destructive method for determining the moisture content in a hygroscopic material |
| 07/29/2010 | WO2010045495A3 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 07/29/2010 | WO2010041865A3 Method and kit for semen diagnosis through colour changes in methylene blue and semen quality evaluation using same |
| 07/29/2010 | WO2010040024A3 Methods, compositions and kits for high throughput kinase activity screening using mass spectrometry and stable isotopes |
| 07/29/2010 | WO2010039921A3 Methods and systems for optically characterizing a turbid material using a structured incident beam |
| 07/29/2010 | WO2010033282A3 Pipeline inspection |
| 07/29/2010 | WO2010009735A9 Combinatorial analysis and repair |
| 07/29/2010 | WO2009148527A8 Mass spectrometer output analysis tool for identification of proteins |
| 07/29/2010 | WO2006009890A9 Methods and compositions for producing insulin sensitization |
| 07/29/2010 | US20100192235 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 07/29/2010 | US20100192032 System and Method for Correcting Primer Extension Errors in Nucleic Acid Sequence Data |
| 07/29/2010 | US20100191478 Method for estimating the level of ethanol in a fuel |
| 07/29/2010 | US20100191474 Electronic nose device with sensors composed of nanowires of columnar discotic liquid crystals with low sensititive to humidity |
| 07/29/2010 | US20100191382 Method and apparatus for fluid dispensation, preparation and dilution |
| 07/29/2010 | US20100191084 Sensor with layered electrodes |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190962 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2010 | US20100190868 Photochromic and electrochromic compounds and synthesis and use thereof |
| 07/29/2010 | US20100190843 Tubulin Isotype Screening in Cancer Therapy Using Halichondrin B Analogs |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190719 Peptides as antimicrobial agents towards campylobacter spp |
| 07/29/2010 | US20100190710 Il-23 receptor antagonists and uses thereof |
| 07/29/2010 | US20100190697 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 07/29/2010 | US20100190692 Methods for reducing gnrh-positive tumor cell proliferation |
| 07/29/2010 | US20100190690 Biomimetic particles and films for pathogen capture and other uses |
| 07/29/2010 | US20100190686 Novel secreted proteins of adipocytes for diagnostic purposes |
| 07/29/2010 | US20100190685 Prognostic factor in sarcoma, and metastasis inhibitor |
| 07/29/2010 | US20100190662 Methods and materials for detection, diagnosis and management of ovarian cancer |
| 07/29/2010 | US20100190659 Compositions and Methods for Diagnosing and Assessing Inflammatory Myopathies |
| 07/29/2010 | US20100190658 Colorimetric assay for the visual detection of primary and secondary amines |
| 07/29/2010 | US20100190655 Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 07/29/2010 | US20100190652 Biomarkers for Detection of Neonatal Sepsis in Biological Fluid |
| 07/29/2010 | US20100190650 Transcriptomic biomarker of myocarditis |
| 07/29/2010 | US20100190271 Methods using novel chemiluminescent labels |
| 07/29/2010 | US20100190270 System and methods for detecting a gaseous analyte in a gas |
| 07/29/2010 | US20100190269 Device, system and method of detecting targets in a fluid sample |
| 07/29/2010 | US20100190268 Assay Device, System and Method |
| 07/29/2010 | US20100190266 Method for measuring bonding activity of antibody which mimics antibody-dependent cell medicated cytotoxic activiy |
| 07/29/2010 | US20100190265 Fluidics device for assay |
| 07/29/2010 | US20100190264 Genetic Variants Increase the Risk of Age-Related Macular Degeneration |
| 07/29/2010 | US20100190262 Diagnostic agent for urinary protein of cat |
| 07/29/2010 | US20100190261 Protein analysis method using isotope compound as label |
| 07/29/2010 | US20100190260 Method for identifying naphthenates in a hydrocarbon containing liquid |
| 07/29/2010 | US20100190247 Methods of Generating Variant Proteins with Increased Host String Content |
| 07/29/2010 | US20100190232 Functional Mutations In Respiratory Syncytial Virus |
| 07/29/2010 | US20100190205 Tissue Cassette Label |
| 07/29/2010 | US20100190200 Diagnosis of Gynecological Neoplasms By Detecting The Levels of Oviduct-Specific Glycoprotein |
| 07/29/2010 | US20100190194 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 07/29/2010 | US20100190192 Method of diagnosing pre-eclampsia |
| 07/29/2010 | US20100190191 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals |
| 07/29/2010 | US20100190190 collecting a sample of saliva, screening the sample to detect a level of at least one of an IgA or IgM antibody to a particular food ingredient or composition; for dogs |
| 07/29/2010 | US20100190189 Methods for detecting biomolecules in a sample |
| 07/29/2010 | US20100190188 Mutant g-protein coupled receptors and methods for selecting them |
| 07/29/2010 | US20100190187 Screening Assays for Antagonists and Analyses of Cardiac Hypertrophy |
| 07/29/2010 | US20100190186 Method for Pathogen Capture from Mammalian Blood |